The selective rho kinase inhibitor trans-6-((4-aminocyclohexyl)amino)-5-fluoro-2-methoxynicotinamide ameliorates monocrotaline-induced pulmonary hypertension
26 August 2017 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
R&D Chiesi Farmaceutici S.P.A., Parma (Italy)
13 More presentations in this session
Access the full session
The Event
ESC Congress 2017
26 August 2017
11:00 CET
